AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 2 filers reported holding AXSOME THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,981,214 | +12.2% | 56,964 | +15.3% | 1.84% | +13.5% |
| Q2 2023 | $3,549,884 | -5.3% | 49,400 | -18.7% | 1.62% | -46.8% |
| Q1 2023 | $3,748,540 | -11.8% | 60,774 | +10.2% | 3.05% | +21.0% |
| Q4 2022 | $4,251,714 | +464.6% | 55,124 | +226.4% | 2.52% | +487.0% |
| Q3 2022 | $753,000 | +14.1% | 16,886 | +44.8% | 0.43% | -12.2% |
| Q1 2021 | $660,000 | -26.4% | 11,664 | +5.9% | 0.49% | -14.5% |
| Q4 2020 | $897,000 | +109.6% | 11,013 | +83.2% | 0.57% | +83.7% |
| Q3 2020 | $428,000 | -25.0% | 6,012 | -13.4% | 0.31% | -34.0% |
| Q2 2020 | $571,000 | – | 6,941 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,123,929 | $42,462,000 | 36.04% |
| MORGAN JESS S & CO INC | 114,525 | $4,327,000 | 2.66% |
| Fairmount Funds Management LLC | 187,598 | $7,087,000 | 2.34% |
| WMS Partners, LLC | 242,500 | $9,162,000 | 1.95% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 610,064 | $23,048,000 | 1.41% |
| MANGROVE PARTNERS IM, LLC | 400,000 | $15,112,000 | 0.90% |
| RTW INVESTMENTS, LP | 1,618,819 | $61,159,000 | 0.89% |
| MPM BioImpact LLC | 103,405 | $3,907,000 | 0.71% |
| Avidity Partners Management LP | 775,000 | $29,280,000 | 0.62% |
| FIRST MIDWEST BANK TRUST DIVISION | 115,028 | $4,346,000 | 0.56% |